GREENHAVEN ASSOCIATES INC, a registered investment adviser, initiated a new position in Avantor, Inc. (NYSE:AVTR) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 20,500,653 shares of the Healthcare company, valued at approximately $234,937,483 as of the filing date.
Avantor, Inc.'s stock currently trades at $12.08 with a market capitalization of $7,817,007,358.
